Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04033510 · ClinicalTrials.gov registry record
Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)
A clinical trial of Atrial Fibrillation and Cognitive Impairment, sponsored by David Brunk, PA-C, MMS.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT04033510 is a study of Atrial Fibrillation and Cognitive Impairment that is active but no longer recruiting, run by David Brunk, PA-C, MMS. The registered enrollment target is 600 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04033510, a study of Atrial Fibrillation and Cognitive Impairment, is active but no longer recruiting, sponsored by David Brunk, PA-C, MMS.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives: * First, to determine if patients with a history of AF have acute measurable changes in cognitive functioning while in an episode of AF. * Second, to collect basic insight into what specific physiologic (blood pressure, pulse oximetry, heart rate, temperature) and pharmacologic (antiarrhythmic medications, rate control medications, anticoagulants, antiplatelet medications, etc.) factors minimize the neurological impact on patients while they are in AF. It is hypothesized that when using a tablet-based cognitive testing software - Cambridge Cognition (specifically to assess executive function, learning and working memory: Rapid Visual Information Processing test, Spatial Working Memory/Spatial Span Task tests, One touch Stockings of Cambridge test, Cambridge Gambling Task, Multitasking Test/Intra-Extra Dimensional Set shift tests) - a significant difference will be noted between how the patients perform while in atrial fibrillation compared to the patients' performance while in normal sinus rhythm.
Conditions Studied
Interventions
- OTHER Standard of Care Interventions to convert patient from atrial fibrillation to normal rhythm
Study Locations (1)
Colorado
- Penrose St. Francis - Colorado Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2027-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04033510
The ClinicalTrials.gov registry entry for NCT04033510 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (80% lower). The listed sponsor is David Brunk, PA-C, MMS, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care Interventions to convert patient from atrial fibrillation to normal rhythm is the first listed.
NCT04033510 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04033510 about?
NCT04033510 is a clinical study titled "Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)". Objectives: * First, to determine if patients with a history of AF have acute measurable changes in cognitive functioning while in an episode of AF. * Second, to collect basic insight into what specific physiologic (blood pressure, pulse oximetry, heart rate, temperature) and pharmacologic (antiarr...
What is the current status of trial NCT04033510?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2019-08-14. Estimated completion is 2027-01-30.
What conditions does trial NCT04033510 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Cognitive Impairment, Cognitive Change, Executive Dysfunction, Cognitive Impairment, Mild.
What interventions are being tested in trial NCT04033510?
The interventions under investigation include: Standard of Care Interventions to convert patient from atrial fibrillation to normal rhythm (OTHER).
Who is sponsoring clinical trial NCT04033510?
This trial is sponsored by David Brunk, PA-C, MMS, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04033510 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.